Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14976934 | 0.85 | KDM4E (0.38) | KDM4E | |
| SCHEMBL14976103 | 0.85 | ADRA1D (0.34) | KDM4E | |
| SCHEMBL14976966 | 0.81 | KDM4E (0.34) | KDM4E | |
| SCHEMBL29669953 | 0.79 | KDM4E (0.59) | KDM4E | |
| SCHEMBL951068 | 0.79 | KDM4E (0.59) | KDM4E | |
| SCHEMBL14977066 | 0.78 | KDM4E (0.40) | KDM4E | |
| SCHEMBL15754618 | 0.78 | KDM4E (0.40) | KDM4E | |
| Ethane SCHEMBL28184948 | 0.77 | KDM4E (0.58) | KDM4E | |
| SCHEMBL19125812 | 0.76 | KDM4E (0.42) | KDM4E | |
| SCHEMBL21990971 | 0.76 | KDM4E (0.42) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9556141-B2 | Process for preparing N-substituted 1H-pyrazole-5-carboxylate compounds and derivatives thereof | BASF SE (DE) | 2017-01-31 | — | — | US | disclosed |
| EP-2782910-B1 | PROCESS FOR PREPARING N-SUBSTITUTED 1H-PYRAZOLE-5-CARBOXYLATE COMPOUNDS AND DERIVATIVES THEREOF | BASF SE (DE) | 2016-02-03 | — | — | EP | disclosed |
| US-20150087843-A1 | Process for preparing N-substituted 1H-pyrazole-5-carboxylate compounds and derivatives thereof | BASF SE (DE) | 2015-03-26 | — | — | US | disclosed |
| EP-2782910-A1 | PROCESS FOR PREPARING N-SUBSTITUTED 1H-PYRAZOLE-5-CARBOXYLATE COMPOUNDS AND DERIVATIVES THEREOF | BASF SE (DE) | 2014-10-01 | — | — | EP | disclosed |
| WO-2013076092-A1 | PROCESS FOR PREPARING N-SUBSTITUTED 1H-PYRAZOLE-5-CARBOXYLATE COMPOUNDS AND DERIVATIVES THEREOF | BASF SE (DE) | 2013-05-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150087843-A1 | Process for preparing N-substituted 1H-pyrazole-5-carboxylate compounds and derivatives thereof | CA5B, CA5A, PC | KDM4E 2314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.